Adani Wilmar on Monday posted over twofold jump in consolidated net profit at Rs 410.93 crore for December quarter 2024-25 on ...

India's Adani Wilmar reported a two-fold surge in third-quarter profit on Monday, buoyed by higher demand in its core edible ...

Adani Wilmar announced a 104.5% increase in Q3FY25 consolidated net profit, reaching ₹411 crore, up from ₹201 crore last year ...

Results: Adani Wilmar's profit surged 104% YoY in Q3 to Rs 411 crore, with revenues growing 31% to Rs 16,859 crore. Edible ...

Adani Wilmar Ltd (BOM:543458) reports impressive revenue and profit growth, while navigating market share and pricing pressures.

For Q3 FY25, the company said operating EBITDA was at Rs 792 crore with a PAT (profit after tax) of Rs 411 crore.

Adani Wilmar's Q3 net profit more than doubled to Rs 411 crore, driven by strong edible oil sales. Revenue also grew ...

Today, companies including Religare Enterprises, Gland Pharma, Fortis Malar Hospitals, Aditya Birla Capital, Alembic Pharma, ...

Adani Wilmar Ltd reported its best-ever quarter in terms of revenue, Ebitda  and PAT, which surged 31 per cent, 57 per cent ...

Results: The firm reported its best-ever quarterly performance in Q3 FY25, driven by robust growth in edible oils and Food & ...

Adani Wilmar reports over twofold jump in net profit for December quarter 2024-25, driven by strong edible oil sales.

Revenue from edible oil segment increased to Rs 13,386.71 crore from Rs 9,710.82 crore in the year-ago period.